Friday, June 10, 2011

Pfizer looks to mobile to help with clinical reporting

Pin It Now!
Pfizer is one of the first companies to look to mobile tools to help recruit and run a clinical trial that will not need their participants to step foot in a clinic. In the new trial for Detrol, Pfizer will compare the data collection and value to the traditional methods of collecting clinical trail data. According to Mobi Health News, This allows any one in the nation to participate in the trial. Pfizer sees this as one way to potentially cut costs off of the rising price to bring drugs to market.

Janet Woodcock, MD, director, Center for Drug Evaluation and Research at FDA recently stated, “Modernization of clinical trials is a key initiative of FDA. We commend Pfizer’s progress on the REMOTE pilot and encourage all manufacturers considering other novel ideas in advancing clinical trials to have prospective discussions with the Agency regarding trial design and oversight.”

ePharma Summit West is so much more than social media. With dozens of representatives from the largest pharmaceutical companies converging to talk about everything from social media, mobile technology, integration of plans and more, you’ll be sure to find everything you need in California this July. Register using the code XP1656BLOG to save 10%. Hurry, current rates expire July 1st!

We see mobile use of Pharma companies increasing. What do you view as some of the benefits that mobile will provide to Pfizer in this clinical trial?
Post a Comment